Andrew Lo Bridge Bio Pharma, Inc. (BBIO) insider trading activity

BBIO Quotes by TradingView

Andrew Lo is Director of BridgeBio Pharma, Inc.. Currently has a direct ownership of 14,089 shares of BBIO, which is worth approximately $935,368. The most recent transaction as insider was on Nov 17, 2025, when has been sold 40,599 shares (Common Stock) at a price of $66.84 per share, resulting in proceeds of $2,713,637. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.1K
74.24% 3M change
70.71% 12M change
Total Value Held $935,368

Andrew Lo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2025
SELL
Open market or private sale
$2,713,637 $66.84 p/Share
40,599 Reduced 74.24%
14,089 Common Stock
Jun 20 2025
BUY
Grant, award, or other acquisition
-
6,589 Added 10.75%
54,688 Common Stock
Dec 30 2021
BUY
Open market or private purchase
$21,450 $14.3 p/Share
1,500 Added 3.02%
48,099 Common Stock
Dec 29 2021
BUY
Open market or private purchase
$77,400 $12.9 p/Share
6,000 Added 11.41%
46,599 Common Stock

Also insider at

ABCL
AbCellera Biologics Inc. Healthcare
Director
ROIV
Roivant Sciences Ltd. Healthcare
AL

Andrew Lo

Director
London, X0

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BBIO